Volume 20, Issue 2, 2020
Gene Therapy (Part II)
Pp: 83-83
Author(s): Zhi-Yao He and Xi-Biao Jia
DOI: 10.2174/156652322002200821100006
Systemic Therapy for Hepatocellular Carcinoma: Advances and Hopes
Pp: 84-99
Author(s): Chen-Hao Zhang, Ming Li, You-Pei Lin and Qiang Gao*
DOI: 10.2174/1566523220666200628014530
NF1, Neurofibromin and Gene Therapy: Prospects of Next-Generation Therapy
Pp: 100-108
Author(s): Xi-Wei Cui, Jie-Yi Ren, Yi-Hui Gu, Qing-Feng Li* and Zhi-Chao Wang*
DOI: 10.2174/1566523220666200806111451
CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy
Pp: 109-126
Author(s): Yang-Hong Ni, Xia Zhao* and Wei Wang*
DOI: 10.2174/1566523220666200623170738
Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China
Pp: 127-141
Author(s): Yu Xia, Xiuqin Li* and Wei Sun
DOI: 10.2174/1566523220999200731003206
Gene Therapy for Hemophilia A: Where We Stand
Pp: 142-151
Author(s): Miaojin Zhou, Zhiqing Hu, Chunhua Zhang, Lingqian Wu, Zhuo Li* and Desheng Liang*
DOI: 10.2174/1566523220666200806110849
γ-Aminobutyric Acid Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Inducing TNFAIP3
Pp: 152-161
Author(s): Hanwen Li, Yongyao Wu, Ning Huang, Qi Zhao, Quan Yuan* and Bin Shao*
DOI: 10.2174/1566523220999200727122502